
Eucrisa: A non-steroid ointment for mild to moderate eczema. It can be used on the face and in skin folds, and there is no limit on how long it can be used. Zoryve: A once-daily steroid-free cream for psoriasis, eczema and seborrheic dermatitis. It has no boxed warning and no limit on how long or how much you use it, which is unusual.


Choose for mild to moderate eczema when you want a non-steroid you can use anywhere, for as long as needed.
Choose for psoriasis, eczema or seborrheic dermatitis when you want a once-daily non-steroid with no limit on time or area.
Can you take them together?
Both are steroid-free creams in the same drug family. Most people use one or the other.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.









Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Eczema redness and itch can improve.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.

Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Redness, scaling, and itch can improve.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.
When to Apply: A thin layer twice a day on the inflamed areas, on clean dry skin. Moisturizer goes everywhere, including over the top once it has settled.
How to Start: Twice daily from day one, on the flaring areas only, not over the whole body as a preventive. If the stinging is hard to tolerate, moisturize first and use the ointment straight from the fridge. The stinging usually fades within the first week.
If It Irritates: Burning or stinging for a few minutes after applying is the commonest effect, and usually not an allergy. It settles as the skin heals. Redness spreading beyond where you applied it, or stinging that gets worse rather than better after two weeks, should be reviewed.
If It's Not Working: There is one strength, so there is nothing to increase. Four weeks of proper twice-daily use is a fair trial. After that: a different non-steroid, a short steroid course to break the flare, or a look at what else is driving the rash.
When to Apply: Once a day, at a time you will remember. A thin layer over the affected skin, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts. Moisturizer and sunscreen can go on top once it has absorbed. For the foam, part the hair and apply to the scalp rather than the hair.
How to Start: Once daily from day one, on every affected area. No build-up period, no strength to work through. The common mistake is treating only the worst patches, which makes the result look worse than it is.
If It Irritates: Stinging or mild burning where you apply it settles within a week or two, and moisturizing beforehand helps. Loose stools, headache or feeling slightly sick in the first weeks is a known, usually mild effect of the drug — tell your doctor if it does not pass.
If It's Not Working: Give it 8 weeks of daily use, though itch often eases much sooner. If plaques are unchanged at 8 weeks, the options are a strong steroid for the thickest areas while keeping roflumilast on the rest, adding a vitamin D cream, or moving to light treatment or a systemic medicine. Twice a day does not help.
No blood tests and no routine monitoring. Very little reaches the bloodstream, and what does is broken down quickly, so nothing accumulates.
Monitoring is a review at about four weeks to decide whether it is working. Long term, this is a drug people can stay on: no maximum duration, no limit on the area treated, no rest period. That is the practical difference between it and a topical steroid.
The one thing worth watching is whether it is quietly standing in for treatment that would actually control the disease. Eczema that keeps escaping it needs a different plan, not more months of the same ointment.
No routine blood tests, no boxed warning, no limit on how much body surface you treat, no maximum duration.
What is worth watching has nothing to do with skin. The oral form causes diarrhea, nausea, appetite loss and weight loss in a meaningful number of people, and has been linked to low mood and, rarely, suicidal thoughts. The cream and foam give much lower blood levels, so these are far less common — but they are on the label and your doctor will ask. If you lose weight without trying, or your mood drops, say so.
Otherwise monitoring is a review of whether it is working, around 8 weeks at first. Your doctor will check your history for liver problems, since severe liver impairment rules it out.
Approximate windows, not promises.
First few minutesApplying it: A thin layer twice a day. Stinging or warmth for a few minutes is common, worst in week one.
First few minutesApplying it: Once a day. Possible stinging where you apply it, which usually settles.
Days 1 to 7Adjusting: Stinging is at its worst now. Itch eases before the rash looks different.
Week 2Settling: Redness and scaling fade. Most of the stinging has gone.
Week 4Judge it here: The point the trials measured. A meaningful share of people reach clear or almost clear skin; a meaningful share do not. No change by four weeks means more time will not help.
OngoingFace, eyelids and folds: Its strongest case. Use it on and off as needed: no cumulative limit, no rest period, none of the thinning that limits steroids on thin skin.
Week 1Adjusting: A few people get diarrhea, headache or mild nausea. These come from the drug rather than the skin, and are far less common with the cream than the oral version.
Weeks 1 to 2First change: Itch improves first. In seborrheic dermatitis, flaking and redness often start easing here too.
Weeks 4 to 8Working: Plaques flatten, scale drops away and redness fades. Week 8 is the fair point to judge plaque psoriasis; eczema and seborrheic dermatitis declare themselves around four weeks. Thinner plaques respond faster.
Folds, face and eyelidsWhere it stands out: These sites absorb steroids quickly and thin fast, so a once-daily option with no time limit changes how they are managed.
After clearingHolding: No thinning, so no reason to stop once skin is clear. Many people continue daily; some drop to a few times a week.
Sorted by what to do about them.
Cost is the obstacle here, not safety. It has been brand-name with no stocked generic for most of its life, and the cash price for a large tube is high. Generic availability changes, so ask the pharmacy.
Prior authorization is common. Plans usually want a topical steroid first, sometimes a calcineurin inhibitor too, which is cheaper as a generic. A savings card exists for people with commercial insurance, with terms that change often.
Tube size matters more than with most creams, because it goes on twice a day over an area. A small tube covering a child's whole body lasts days. Ask for the size that matches the area treated.
This is the main reason people do not end up on it. Roflumilast is brand only with no generic, and a tube runs to several hundred dollars or more. Generic steroid creams cost a small fraction of that.
A prior authorization is close to routine. Most plans want to see that a topical steroid was tried and either failed or is not appropriate — the fold, face and eyelid argument usually succeeds, because those are exactly the places long-term steroid use causes harm. Some plans also want a vitamin D cream tried first. Denials are common on the first attempt and often overturned on appeal, so push back.
The manufacturer runs a copay program that can cut the cost substantially with commercial insurance, plus patient assistance for people who qualify. Terms change often. People on government insurance generally cannot use copay cards, which is a real gap.
One practical note: cost is per tube and psoriasis treatment is open-ended, so ask about the largest tube your plan will cover — the price per gram is usually better.
Probably the drug itself acting on inflamed skin, not the base. It is the commonest complaint, worst in the first days, and fades within a week.
Thin skin is where it makes the most sense and it is used there, but not in the eye itself. Keep it off the lid margin.
No, it is milder. Its advantage is delicate skin and long stretches without the thinning that limits steroids.
There is no set limit. On during flares, off in between, for as long as it helps.
It is licensed from three months of age.
Licensed for atopic dermatitis. Doctors sometimes use it off-label for other inflammatory rashes, where the evidence is thinner.
No. It blocks an enzyme called PDE4 inside inflammatory cells. It does not thin skin, which is why it can go on the face, eyelids and folds without a time limit.
There is no fixed maximum. The rule about stopping after a few weeks comes from steroid creams. Long-term daily use with regular review is normal.
Once daily is what the trials tested. Twice does not clear skin faster and makes stomach side effects more likely.
Usually not. Diarrhea, nausea and headache are listed because they can happen, and are common with the oral version used for lung disease. Blood levels from the cream and foam are much lower.
The drug is the same. The foam lets it spread through hair and over the scalp, and it is the form used for seborrheic dermatitis. The 0.3% cream is for psoriasis and the 0.15% cream for eczema.
Clearing inflammation often leaves a dark or pale patch. Not active disease, and it fades over months. It shows up more on deeper skin tones.
A common approach — a strong steroid for the thickest patches, roflumilast for the face, folds and the rest. Plan it with your doctor rather than layering both on one spot.